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INTRODUCTION 
 
  Integrins are the principal cell surface receptors that enable both 
normal and transformed cells to attach to and respond to their extra-cellular 
environment. Integrins mediate cell to cell or cell to extra-cellular matrix 
(ECM) adhesion, providing adhesion for stationary cells. They mediate the 
traction during cell movement and importantly the promotion of many 
signalling pathways that regulated diverse processes including proliferation, 
migration, cell survival, differentiation, tumor invasion and metastasis
1
.  
             Oral Potentially Malignant Disorders are Erythroplakia, Leukoplakia, 
Oral Submucous Fibrosis (OSF), and Erosive Lichen Planus. In erythroplakia 
the malignant transformation   rate is 90%.  Leukoplakia has a   malignant 
transformation rate of 3.6-17.5%.  Some authors say that OSF has a malignant 
transformation rate of about 0.5-6%. Malignant transformation rate of erosive 
lichen planus is reported to be less than 0.4-3.7% (Pei-Shan Ho et al) 
63
. 
             Oral submucous fibrosis (OSF) is a premalignant, fibrosing disorder 
of the mouth, pharynx and oesophagus, with a malignant transformation rate 
of 7-13%
5
. The frequency of malignant change in lichen planus ranges from 
0.4 to 3.3% (Scully et al, 1998)
  
and 17% of  oral leukoplakia  may progress to 
malignany of the oral cavity (Gupta et al, 1980; Silverman et al, 1984) 
2
.  
            The integrin αvβ6 was highly expressed throughout the whole lesion in 
90% of the squamous cell carcinoma, in 41% of the leukoplakia specimens, 
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85% of the lichen planus samples and over 80% of oral submucous fibrosis 
related oral cancers, but is not expressed in tissues with inflammatory 
hyperplasia or chronic inflammation 
2,5. The expression of αvβ6 integrin could 
be associated to the malignant transformation of oral leukoplakia and lichen 
planus
  
and oral submucous fibrosis. Potentially malignant lesions are an 
immune inflammatory process and if persistent will result in activation of 
oncogenes and loss of tumor suppressor genes
5
. In carcinogenesis, epithelial 
cells breach the basement membrane and proliferate and migrate within the 
connective tissues
3
. 
             Although epithelial cell may express a variety of cell-adhesion 
molecules, integrins are the most important extracellular matrix (ECM) 
receptors and are known to play a major role in tumor invasion and 
progression
3. Integrin αvβ6 is also expressed to a certain extent among cases 
of verrucous hyperplasia, verrucous carcinoma, carcinoma in situ and lichen 
planus and clinically diagnosed leukoplakia lesions. However epithelial cells 
of inflammatory, drug-induced or idiopathic hyperplasia or chronic 
inflammatory lesions do not express αvβ6 integrin26. 
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AIM AND OBJECTIVES 
 
The aim of this study is to investigate expression of αvβ6 integrin in 
potentially malignant lesions. 
1. Detection of αvβ6 integrin in Mild dysplasia (n=10), Moderate and 
Severe dysplasia (n=10) by immunohistochemistry (IHC). 
2. Detection of αvβ6 integrin in Oral submucous fibrosis (n=10) by IHC.  
3. Detection of αvβ6 integrin in normal healthy mucosa (n=10) by IHC. 
HYPOTHESIS (Null) 
       αvβ6 integrin is not expressed  in potentially malignant lesions.   
STUDY SETTING 
The study was conducted in the Department of Oral and Maxillofacial 
Pathology, Ragas Dental College and Hospital, Chennai, using archival 
formalin-fixed-paraffin embedded blocks of mild, moderate, severe epithelial 
dysplasia, oral submucous fibrosis and normal mucosa using IHC. This study 
was approved by Institutional Review Board (IRB) of Ragas Dental College 
and Hospital, Chennai (Annexure I). 
STUDY SUBJECTS: 
The study material comprised of 40 formalin-fixed, paraffin embedded 
tissue specimens. The samples were divided into 4 groups namely: Group I, 
Group II, Group III and Group IV. 
Group I: 10 normal oral mucosal tissue specimens. 
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Group II: 10 histopathologically confirmed mild epithelial dysplasia tissue 
specimens 
Group III: 10 histopathologically confirmed moderate and severe epithelial 
dysplasia tissue specimens 
Group IV: 15 histopathologically confirmed oral submucous fibrosis tissue 
specimens 
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MATERIALS AND METHODS 
 
1. Tissue samples of normal oral mucosa (n=10), Mild dysplasia (n=10), 
Moderate and Severe dysplasia (n=10), Oral submucous fibrosis 
(n=10), were taken from archival blocks. 
2. A detailed case history including patient’s age, gender, occupation, 
past medical & dental history, history of drugs and trauma were 
recorded. 
3. Extra oral and intra oral examination was done. 
4. Biopsy was performed from the lesional site. Normal oral mucosa was 
taken when the patients were undergoing minor surgery for extraction 
of impacted teeth. 
5. The tissue biopsied was immediately transferred to 10% buffered 
formalin. 
6. After adequate fixation, tissue was embedded in paraffin. 
7. From the paraffin embedded blocks 5 microns thick, sections were cut 
and used for routine hematoxylin and eosin (H & E) staining and 
immunohistochemical (IHC) staining. 
8. Tissue sections of placenta were used as positive control for αvβ6 
integrin positivity. 
9. During embryogenesis αvβ6 is expressed at high levels in the 
developing lung, skin and kidney and which is not expressed on 
healthy oral epithelium but is upregulated during tissue remolding, 
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including wound healing, carcinogenesis and fibrosis 
11, 4. αvβ6 binds 
to its ligand via the tripeptide recognition sequence arginine – glycine 
– aspartic acid (RGD). Known ligands of  αvβ6 are extracellular 
proteins such as fibronectin, tenascin-C, vitronectin, Latency-
associated  peptide of TGF-β1 and TGF-β3. 
HEMATOXYLIN AND EOSIN (H & E) STAINING 
REAGENTS 
 Harris’s hematoxylin 
 1% acid alcohol 
 Eosin 
 Xylene 
 Alcohol 
PROCEDURE 
   The slides were dewaxed in xylene and hydrated through graded 
alcohol to water. The sections on the slides were flooded with Mayer’s 
hematoxylin for 5 minutes. The slides were washed in running tap water for 5 
minutes. The slides were differentiated in 1% acid alcohol for 5 minutes. The 
slides were washed well in running tap water for 5 minutes. The tissue 
sections on the slides were then stained in eosin for 30 seconds. The slides 
were washed in running tap water for 1 minute. The slides were then 
dehydrated through alcohol, cleared, mounted and viewed under light 
microscope (LM). 
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IHC STAINING (αvβ6 INTEGRIN)                                                                                  
Armamentarium:- 
 Microtome 
 Autoclave 
 Hot air oven 
 Slide warmer 
 Couplin jars 
 Measuring jar 
 Weighing machine 
 APES coated slides (Amino propyl triethoxysilane) 
 Slide carrier 
 Aluminium foil 
 Micro-pipettes 
 Toothed forceps 
 Electronic timer 
 Beakers 
 Rectangular steel tray with glass rods 
 Sterile gauze 
 Cover-slips  
 Light microscope 
  REAGENTS USED 
1. APES (3 amino propyl triethoxysilane) 
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2. 0.1 mol/L citrate buffer (50X)   
3. 0.45% H2O2 
4. DAB detection system 
5. Distilled water 
6. Mayer’s Hematoxylin 
ANTIBODIES USED 
1. Primary antibody – Anti αvβ6 integrin rabbit (bs-5791R) polyclonal 
antibody -   Biotech desk, 
2. Secondary antibody – Poly excel- HRP micro polymer IHC detection 
system – Pathnsitu.  
PREPARATION OF PARAFFIN SECTION                                                                                                                           
  After the slides were dried, tissue sections of 5 micron thickness were 
made in a rotary manual microtome. The ribbons of tissue section were 
transferred onto the APES coated slides from the tissue float bath such that 
two tissue bits come on to each slide with a gap in between. One of the tissue 
sections towards the frosted end of the slide was labeled negative to which 
negative serum, the secondary and the chromogen were added and the tissue 
section away from frosted side is the positive to which the primary antibody, 
secondary antibody and chromogen were added. 
IMMUNOHISTOCHEMISTRY PROCEDURE 
  Frozen sections (6µm) were cut and fixed with -20°C acetone for 5 
minutes and stored at -70°C until used. Antigen retrieval of primary antibody 
was microwaving for 30 min in 0.1 mol/L citrate buffer (Ph- 6).  Endogenous 
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peroxidase was neutralized with 0.45% hydrogen peroxidase in methanol for 
15 min and primary antibodies were applied in TBS (pH 7.6) for 1 hour. Poly 
excel HRP secondary antibody applied for 30 min. Peroxidase was visualized 
using DAB+ for 7 min and counter stained in Mayer’s hematoxylin and Slides 
were then washed in distilled water to remove excess chromogen. The tissue 
sections were mounted with DPX. The slides were then observed under the 
microscope. Throughout the procedure care was taken not to dry the tissues.                                                                                                                                                      
POSITIVE CONTROL 
  The Placenta contains Chorion and amnion layer. Placenta and fetal 
membranes from normal vaginal deliveries exhibited strong intensity of 
staining for αvβ6 integrin in the epithelial layer of the amnion. A case of 
placenta specimen known to express Alpha v beta 6 integrin positivity were 
fixed, processed, embedded, sectioned, stained in same manner and used as 
positive control. One positive control tissue slide was included for each batch 
of staining. The tissue section away from the frosted end of the slide was taken 
as the positive control. 
IHC PROCEDURE 
1. APES coated slides with 2 paraffin embedded tissue fixed with -20°C 
acetone for 5 minutes and stored at -70°C until used.  
2. Keep in citrate buffer (pH 6) for 30 minutes at 37ºC for antigen 
retrieval. 
3. Neutralized with 0.45% hydrogen peroxidase in methanol for 15 
minutes. 
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4. Primary antibodies were applied in TBS (pH 7.6) for 1 hour.  
5. Poly excel HRP secondary antibody - was applied for 30 minutes. 
6. DAB detection system was applied. 
7. Counter stained in Mayer’s hematoxylin for 7 minutes. 
8. Slides were then washed in distilled water to remove excess 
chromogen. 
9. Slides to be mounted using dibutyl phthalate styrene (DPX). 
10. Slides to be observed under the light microscope and graded. 
CRITERIA FOR EVALUATION OF STAINING 
Evaluation of H & E sections:  
 The H & E stained sections were thoroughly examined.  
 Oral dysplasia was graded as mild, moderate and severe dysplasia 
and  were examined. 
 Oral submucous fibrosis cases were also examined. 
Evaluation for IHC: 
 Corresponding sections as examined by H & E were stained by IHC to 
detect αvβ6 
expression. 
 The positive control used for IHC was normal membrane and placenta. 
 Positive cells were counted in the epithelial cells of normal mucosa, 
oral submucous fibrosis, mild dysplasia, moderate dysplasia, severe 
dysplasia.  
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 The staining intensity of αvβ6 was scored on a scale of 1 to 3 (1-weak, 
2-moderate, and 3-strong), and the proportion of cells staining 
positively was scored on a scale of 1 to 4 (1- focal basal, 2-linear basal, 
3-basal and Suprabasal, and 4-full epithelium thickness). The score for 
intensity was added to the score for proportion to give a score in the 
range of 0 to 7 and grouped as score = 0 (-), score = 1–4 (low), score = 
5-7 (high). 
TISSUE LOCALISATION: 
  αvβ6 stain is localized to the basal, suprabasal and full thickness of the 
epithelium. 
CELLULAR LOCALIZATION OF STAIN 
  The normal localization of the staining includes both nucleus and 
cytoplasm. In our study the stain is localized to the cytoplasmic region. But 
the stain is not present in normal tissue. The stained slides were screened, 
examined systematically for αvβ6 integrin expression in the cytoplasmic 
portion.  
INTENSITY OF STAINING 
  The staining intensity of αvβ6 was scored on a scale of 1 to 3 (1-weak, 
2-moderate, and 3 strong), and the proportion of cells staining positively was 
scored on a scale of 1 to 4 (1- focal basal, 2-linear basal, 3-basal and 
Suprabasal, and 4-full thickness of the epithelium thickness). The score for 
intensity was added to the score for proportion to give a score in the range of 0 
to 7 and grouped as score = 0 (-), score = 1–4 (low), score = 5-7 (high)  
Materials and Methods 
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intensively stained based on the intensity of staining taken up by the tissue as 
observed by two blinded observers independently with respect to positive 
control. 
STATISTICAL ANALYSIS 
  Data were entered and analyzed using SPSS
TM
 software (version 21.0). 
Pearson’s Chi-square test done to compare intensity of staining between two 
groups. p value >0.05 was considered statistically significant. Kappa analysis 
was done to compare the intensity of αvβ6 integrin staining as observed 
between three observers. 
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STRUCTURE OF INTEGRIN 
 
 
 
 
 
 
 
 
 
   
 
 
 
Representation of prototype αI-domain containing integrin heterodimer. αI(αA)-domain is part of  
 
the α-subunit and connected to the seven-bladed β-propeller domain. There are nine different  
 
types of integrins that contain αI domain. This domain contains Rossman fold and a MIDAS site  
 
for metal ion binding. β-propeller domain contains EF-hand motif for calcium binding and is  
 
connected with thigh domain followed by calf-1 and calf-2 domains. β-subunit contains a  
 
β1(βA)- domain that process structural similarity with αI domain. This domain also contains  
 
Rossman fold and MIDAS site for metal ion binding. The interface of βI domain of β-subunit  
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and β-propeller domain of α-subunit forms a ligand binding pocket. βI-domain is connected to  
 
hybrid domain followed by a plexin-somaphorin-integrin (PSI) domain, four EGF repeats and a  
 
β-tail domain4. 
STRUCTURE OF αvβ6 INTEGRINS 
(1)Structurally, integrins are hetrodimers composed of two different, non-covalently associated, 
α and β subunits. They appear by electron microscopy to have a large extra-cellular domain 
composed of a membrane distal, globular head that contains the ligand binding site, on two long 
stalks.                                                                                                                                                               
(2) The carboxy-(C) termini of the α and β subunits traverse the cell membrane and extend a 
short distance into the cytoplasm
1
. 
 
 
 
 
 
LIGAND 
EXTRA CELLULAR MATRIX 
CYTOPLASAM 
PLASMAMEMBRANE 
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THE VARIOUS HETERODIMERIC COMBINATIONS OF α AND β SUBUNITS25. 
                                    INTEGRIN FAMILY OF PROTEINS AND THEIR LIGANDS
 
β1 α1 Colls, laminins 
α 2 Colls, laminins, chondroadherin 
α 3 Laminins (such as laminin-1, -5, -8, -10, and -11), Fn, thrombospondin, TIMP-2, 
uPAR, collagen, epiligrin, entactin 
α 4 Fn, VCAM 
α 5 Fn, Fg, Upar 
α 6 Laminins, merosin (laminin α2 chain), Kalinin 
α 7 Laminins, merosin (laminin α2 chain), 
α 8 Fn, vitronectin, Tn-C, osteopontin, and nephronectin 
α 9 angiostatin, Tn-C, osteopontin, and ADAMs, VCAM-1, tTG, 
α 10 Colls 
α 11 Colls 
α v Fn, vitronectin 
β 2 α L ICAM-1, -2 and -3 
α M Fg, ICAMs, iC3b, factor-Xa, denatured ovalbumin 
α X Fg, iC3b 
α D VCAM, ICAMs 
β 3 α IIb Coll, Fn, vitronectin, Fg, vWF, thrombospondin 
α v Fn, vitronectin, Fg, vWf, thrombospondin, FGF-2, MMP-2 and some ADAM 
proteins 
β 4 α 6 Laminins 
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β 5 α v Vitronectin, Upar 
β 6 α v Fn, Tn 
β 7 α 4 Fn, VCAM, MAdCAM 
α E E-cadherin 
α v Colls, laminins, Fn 
β N α v Fn, Colls 
β 8 α v Vitronectin, Fn 
 
Abbreviations used are 
Colls: collagens; Fn: fibronectin; TIMP-2: tissue inhibitor of metalloproteinase;  
uPAR: urokinase-type plasminogen activator (uPA) receptor; VCAM: vascular cell adhesion 
molecule; Fg: fibrinogen; Tn-c: tenacin-C; ADAMs: a disintegrin and metalloproteinase 
proteins; tTG: tissue-type transglutaminase; iC3b:inactivated complement component 3b; ICAM: 
intercellular cell adhesion molecule; vWf: vonWillebrand factor; FGF-2: fibroblast growth factor 
2; MMP: matrix metallo-proteinases and MAdCAM: mucosal addressin cell adhesion molecule. 
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 LIGAND OF αvβ6 INTEGRIN10 
Ligand  Type of protein 
Fibronectin               ECM protein 
Tenascin-C ECM protein 
Vitronectin ECM protein 
LAP of TGFb-1                      Cytokine 
LAP of TGFb-3 Cytokine 
Foot-and-mouth disease virus 
(FMDV) 
Viral capsid 
Coxsackievirus 9 (CAV-9) Viral capsid 
 
Activation of different matrix metalloproteinases by αvβ6 in various cancers. Activation of 
MMP9 has the highest prevalence
15
. 
                                  KERATINOCYTES INTEGRINS
7
 
INTEGRINS MAJOR LIGAND EXPRESSION 
α2β1 Collagen Constitutive (Basal layer) 
α3β1 Laminin Constitutive (Basal layer) 
α6β4 Laminin Constitutive (Basement membrane) 
αvβ5 Vitronectin Weak (buccal mucosa) 
α5β1 Fibronectin Induced in culture, on wounding, in pathological conditions 
αvβ6 Fibronectin; tenascin Induced in culture, on wounding, in pathological conditions 
α9β1 Tenascin Upregulated during wound healing 
αvβ8 Vitronectin Suprabasal 
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INTEGRINS SUPERFAMILY 
  (G. J. Thomas et al 2006) The integrin superfamily 18 α and 8 β subunits have been 
identified combining to form at least 24 hetrodimeric integrins which can be considered in 
several sub families based on ligand specificity. The different subunits show selectivity in their 
binding partners; for example the αv subunit can pair with multiple β subunits (β2, β3, β4, β5, 
β6, β8) but the β6 subunit can only bind with αv1. 
INTEGRIN RECEPTORS 
  (Sumit Goswami et al 2013) There are a total of 24 different types of integrins. The 
integrin family of receptors, depending on their ligand recognition pattern can be broadly 
classified into four different categories
4
.  
I) RGD binding 
II) Collagen binding  
III) Laminin binding 
IV) Leucocyte binding types of integrins  
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RGD – Arginine – Glycine – Aspartic acid                                                                                                                                     
RGD is highly effective in the presence of Ca2+, somewhat less effective in Mg2+, and virtually 
inactive in Mn2+
1
.   
INTEGRIN SIGNALING 
  (Caroline H Damsky et al 2002) Integrins are in the proper relationship with ECM in 
order to respond to signals from growth factors. Integrins recruit growth factors receptors (GFRs) 
as well as cytoskeletal components, adaptor molecules and non-receptor tyrosine kinase to sites 
of adhesion when they are clustered and activated by ECM ligands. They affect cell polarity, 
directed migration, cell growth and survival and differentiation
10
. 
  (Paul H. Weinreb et al 2004)  Integrin signaling is unique among all the cell surface 
receptors because signaling can propagate in both directions (outside to inside and inside to 
outside). Most of the time, cell surface receptor-mediated signaling involves initial binding of the 
ligand on the extracellular domain, which then initiates changes at the cytoplasmic domain 
leading to further propagation of signaling events; this is called outside – in signaling35. Another 
kind of signaling process called inside-out signaling. In this process, binding of intracellular 
ligands to the cytoplasmic domain results in some conformational change in the extracellular 
domain of the receptor
35
.  
 EPIDERMAL HYPERPROLIFERATION AND INFLAMMATION 
  (Fiona M. Watt et al 2002) Suprabasal integrins can activate MAPK directly or via 
stimulating release of interleukin -1α (IL-1α) in cultured human keratinocytes results in 
increased proliferation. MARK is activated through stimulating keratinocytes to release IL-1α. 
IL-1α production by keratinocytes induces a dermal mononuclear infiltrate, leading to release of 
further cytokines and growth factors
7
.
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FUNCTION OF INTEGRIN 
  (John Lamar et al 2011) Several integrins are expressed in normal, unwounded 
epidermis and oral squamous epithelium, including α3β1 and α6β4 (both laminin-332 receptors), 
α2β1 (a collagen receptor), α9β1 (a fibronectin and tenascin receptor) and αvβ5 (a vitronectin 
receptor). Integrin α6β4 is an essential component of hemidesmosomes, which are adhesion 
structures on the basal surfaces of keratinocytes that anchor the epidermis to the dermis
59
. 
Proliferating keratinocytes are normally restricted to the basal cell layer where they are adhered 
through integrins to the underlying basement membrane (BM), a specialized ECM that separates 
epithelial cell layers from adjacent connective tissue. Differentiating keratinocytes down-regulate 
integrin expression as they detach from the BM and are displaced into the suprabasal layers
59
. 
             (Michael Busk et al 1992) Integrins that regulate the activation of ECM- producing cells 
include cytokines, chemokines, growth factors, components of the renin-angiotensin system 
(RAS), angiogenic factors, peroxisome proliferator-activated receptors (PPARs), mammalian 
target of Rapamycin (mTOR), and products of oxidative stress
12
. 
             (G. Latella et al 2013) Integrins regulate cell-cell and cell-extracellular matrix 
interactions, thus influencing growth, differentiation, and development, as well wound healing 
and development of fibrosis
17. αvβ6 ligands include fibronectin, tenascin, vitronectin and 
latency-associated peptide (LAP). αvβ6 integrin inhibit to reduce the tissue levels of pro-
fibrogenic transcripts, such as procollagen α1(I), TGFβ1, TGFβ2, connective tissue growth 
factor (CTGF), tissue inhibitory matrix metelloproteinaseas-1
17
.  
            (G. J. Thomas et al 2006) αvβ6 promotes adhesion and migration on several different 
ECM ligands, which promotes increased MMP secretion and can activate TGFβ1 and TGFβ3, 
which leads to promote the survival of OSCC cells
1. αvβ6 expression  in carcinomas of the lung, 
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breast, pancreas, stomach, colon, ovary, salivary gland as well as oral and skin squamous cell 
carcinoma
1
.
 
 
            (Louise A. Koopman Van Aarsen et al 2008) αvβ6 binding to LAP1 or LAP3 leads to 
activation of the latent precursor form of TGF-β1 and TGF-β3. Thus, up-regulated expression of 
αvβ6 can lead to local activation of TGF-β, Up-regulated αvβ6 expression has been shown to be 
associated with increased epithelial to mesenchymal transition, increased tumor cell invasion, 
and increased metastatic potential in vivo
14
.  Local activation of TGF-β1 and the ability to 
promote tumor progression, invasion, and metastasis. The TGF- β1 cytokine is a pleiotropic 
growth factor that can regulate cell proliferation, differentiation, and immune responses. In vivo 
by a Transforming Growth Factor- β–Regulated Mechanism14. 
             (Karsta Luettich et al 2004) The integrin αVβ6 is expressed principally on epithelial 
cells. Where it has been shown to be a receptor for RGD and non-RGD sites in ligands. The 
mature form of TGFβ1 binds to and activates of αVβ6integrin. Among others, binding of mature 
TGFβ1 to αVβ6 integrin resulted in an enhanced immobilization and phosphorylation of proteins, 
which are associated with focal adhesions. Stimulation with mature TGFβ1 leads to upregulation 
of c-Jun in TGFβ1 sensitive cells. Mature TGFβ1 activates c-Jun via MEKK1/p38 and if this 
activation may influence cytoskeletal reorganization
53
. 
COMPARING THE EXPRESSION OF INTEGRINS 
            (Jens Schittenhelm1 et al 2013) αv integrin subfamily, which has five members αvβ1, 
αvβ3, αvβ5, αvβ6 and αvβ8. The αvβ3 and αvβ5 integrins, which are frequently expressed in 
tumor endothelial cells, which may affect tumor initiation and progression, in lung cancer αvβ3 
and αvβ6 can bind ligands such as osteopontin and fibronectin24. Tumor progression in colorectal 
cancer can be promoted through αvβ6-mediated activation of TGF-β. In pancreatic ductal ade-
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nocarcinoma αvβ6 is upregulated compared to normal ducts. Comparable levels of expression 
only for αvβ3 and αvβ8 were in brain metastasis, while αvβ6 and αvβ5 were higher in 
primaries
24
. 
MATRIX METALLOPROTEINASES (MMPS) AND INTEGRINS  
         (Ylipalosaari et al 2005)  MMPs have several roles in malignant transformation and 
tumour progression. MMPs release cell-membrane bound precursors of growth factors, modulate 
apoptosis mediators, produce angiogenesis inhibitors by cleavage or allow endothelial cell 
invasion into tumour tissue. They also degrade extra cellular membrane (ECM) and basement 
membrane(BM) components, allowing cancer cells to migrate and to invade, and modulate the 
immune response by suppressing lymphocytoproliferation. MMPs contribute to epithelial and 
carcinoma cell migration by cleaving laminin-5, which is a major component of 
hemidesmosomes in BM and promotes static adhesion between the epithelium and BM
26
.                                                                                                                
Integrin αvβ6 overexpression induces production of MMP-3 and -9 and, to a lesser extent,MMP-
2  in both ligand-dependent and -independent manners. Ligation of β6 integrin with fibronectin 
achieves activation of the FYN/FAK complex, which in turn couples β6 signaling to the Raf-
ERK/MAPK pathway. This pathway activates MMP-3 transcription and promotes OSCC cell 
proliferation and metastasis
26
.  
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  (Hai-Xia Li1 et al 2013) αvβ6 regulates expression of MMP-1, MMP-2, MMP-9 and MMP-13 
in OSCC cells
55
. 
 
αvβ6 INTEGRIN EXPRESS IN WOUND HEALING 
            (Kirsi Haapasalmi et al 1996) Integrins are expressed by basal keratinocyte. lntegrins of  
the β1 family were present in normal keratinocytes of oral mucosa, while αv, αvβ5 , and αvβ6 
integrins were absent. In those 3-day-old wounds in which epithelial sheets were fused, αvβ6 
integrin was present in the basal cell layer in the wound area, but absent from the non-wounded 
site
8. αv integrin and αvβ6 integrin complex reacted with basal keratinocytes in all 7-day-old 
wounds. The ligands of αvβ6 integrin are fibronectin and tenascin, in 7-day-old wounds that 
displayed high expression of this receptor. Fibronectin was present throughout the normal  
connective tissue and abundantly in the wound granulation tissue matrix. Tenascin was present 
strongly in subepithelial connective tissue but weakly in deeper areas of the non-affected tissue. 
Specimen were collected from punch biopsies were taken from wounds on 3 and 7
th
 day
8
. 
POTENTIALLY MALIGNANT DISORDERS  
Betel quid chewing was found to be the strongest risk factor for both   dysplasia and   OSF . 
While the effect of alcohol drinking on the two oral premalignant diseases was not substantial, 
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the significantly elevated risk of cigarette smoking was detected among OL patients. Among 
these risk factors, betel quid chewing accounted for 73.2 and 85.4% of attributable risks of 
contracting   dysplasia   and OSF, respectively. Combined with cigarette smoking, the population 
attributable risk proportion of dysplasia increased to 84.4%. In the same way, 86.5% of  the a 
etiologic fraction for patients having either dysplasia or OSF was detected 
27
. 
CLASSIFICATION OF ORAL POTENTIALLY MALIGNANT DISORDERS 
1. High Risk 
Erythroplakia. 
Leukoplakia. 
Oral Submucous Fibrosis (OSF). 
Erosive Lichen Planus. 
2. Life-style Related 
 Smokeless Tobacco Keratosis. 
 Reverse Smoker’s Palate. 
Actinic Cheilitis. 
3. Infections 
Hyperplastic Candidiasis. 
Viral (HPV, HIV, EBV, HBV, HSV). 
Tertiary Syphilis. 
4. Immunodeficiency 
Solid Organ Transplantation. 
Graft Versus Host Disease. 
Chronic Cutaneous Lupus Erythematous. 
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5. Inherited Disorders 
 Xeroderma Pigmentosum. 
Dyskeratosis Congenita. 
Epidermolysis Bullosa. 
Bloom Syndrome. 
Fanconi’s Anemia.  
No single factor has been identified as the causative factor for potentially malignant disorders. 
But a number of high risk factors has been put forwarded which has greater than normal risk of 
malignancy at a future date 
64
. 
A. Extrinsic Factors 
1. Tobacco in any form (smoking or chewing) is the single most major extrinsic cause 
(people   who smoke more than 80 cigarettes per day have 17-23 times greater risk). 
2. Alcohol regardless of beverage type and drinking pattern – synergistic action along with 
tobacco (risk of smokers who are also heavy drinkers is 6-15 times than that of 
abstainers). 
3. Virus infection – HPV, EBV, HBV, HIV, HSV. 
4. Bacterial infection – treponema pallidum. 
5. Fungal infection – candidiasis. 
6. Electro-galvanic reaction between unlike restorative metals. 
7. Ultraviolet radiation from sunlight – associated with lip lesions. 
8. Chronic inflammation or irritation from sharp teeth or chronic cheek-bite (tissue 
modifiers rather than true carcinogens). 
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B. Intrinsic Factors 
1. Genetic (5% are hereditary). 
2. Immunosuppression – organ transplant, HIV. 
3. Malnutrition – iron (anemia), vitamin A, B, C deficiency. 
Most common sites for PMDs in India are buccal mucosa followed by tongue, palate and 
floor of the mouth. Location of PMDs differs from distribution of OSCC, for which the tongue, 
alveolar ridge and floor of mouth are the most common sites 
64
. 
EXPRESSION OF αvβ6 INTEGRIN IN ORAL LEUKOPLAKIA 
               (S Hamidi et al 1999) Fibronectin and tenascin were both present in the connective 
tissue, especially in areas close to the basement membrane zone.  Known ligands of αvβ6 
integrin are extracellular proteins such as fibronectin, tenascin-C, vitronectin, latency-associated 
peptide of TGF-β1 and TGF-β3 via the tripeptide recognition sequence arginine-glycine-aspertic 
acid were expressed underneath the oral epithelium, basal and suprabasal, and at the area near 
the basement membrane zone in the epithelial dysplasia. Specimen was collected from oral 
biopsy specimens of 29 cases of leukoplakia
2
. 
EXPRESSION OF αvβ6 INTEGRIN IN ORAL LICHEN PLANUS 
            (S Hamidi et al 1999) Known ligands of αvβ6 integrin are extra cellular proteins such as 
fibronectin, tenascin-C, vitronectin, latency-associated peptide of TGF-β1 and TGF-β3. αvβ6 
integrin binds to its ligand via the tripeptide recognition sequence arginine-glycine-aspertic acid 
was very strongly present around keratinocytes in basal and suprabasal cell layers of all the 
lichen planus. Specimen was collected from oral biopsy specimens of eight of lichen planus
2
. 
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αvβ6 INTEGRIN EXPRESSION IN ORAL SUBMUCOUS FIBROSIS 
(Karwan A Moutasim et al 2009) The stroma of OSF contained myofibroblasts and that 
TGF-β1-dependent Smad signalling was detectable both in keratinocytes and in myofibroblasts. 
They also found that arecoline, the major alkaloid of areca nuts, up-regulated keratinocyte αvβ6 
expression. Arecoline-dependent αvβ6 up-regulation promoted keratinocyte migration an 
induced invasion, raising the possibility that this mechanism may support malignant 
transformation. Specimens are collected from 41 OSF cases compared with 14 cases of 
fibroepithelial hyperplasia by immunohistochemistry
44
. 
           HYPOTHETICAL MODEL OF αvβ6 ROLE IN OSF PATHOGENESIS 
                                                     Alkaloids implicated in OSF 
                                                        
                                                           Genetic predisposition 
 
αvβ6 integrin 
                                                           
                                                           Activation of TGF-β1 
                                                           
                                              Tansdifferentiation of myofibroblasts 
                                                           
                                                      Upregulation of collagen 1 
                                                        
                                                          Pathological fibrosis 
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The pathogenesis of OSMF involves the mechanical as well as chemical trauma to the 
oral mucosa. The dry arecanut pieces   present in gutkha and pan masala causes microtrauma to 
the oral mucosa. The traumatized mucosa undergoes chronic inflammation due to repeated 
microtrauma and irritation. This   causes the oxidative stress and cytokines production due to 
chronic inflammation. The hypothesis that dense fibrosis and   less vascularity of the corium, in 
the presence of an altered   cytokine activity creates a unique environment for carcinogens 
from both tobacco and arecanut to act on the epithelium is   widely being accepted 
11
.  
  The alkaloid like arecoline, arrecadine, guaccine, tannins, catechins, leaches out in saliva 
from arecanut and acts on the chronically inflamed mucosa. Increased   amount of cytokines 
produced in oral mucosa like fibroblast   growth factor, transforming growth factor and platelet-
derived growth factor increases the production of collagen in the submucosal region. Also the 
inhibitory cytokine in collagen production   interferon-alpha is decreased in oral mucosa which   
leads to decreased degradation of collagen. Alkaloid leached out from areca nut acts on the 
fibroblast and induces the phenotypic changes, which leads to the decreased capacity   of 
fibroblasts to degrade and remodel the collagen fibers in   the   submucosal region. This leads to 
the increased amount of collagen fibers in the submucosal region of oral cavity leading   to 
OSMF. 
  The arecanut   has   psychotropic and antihelminthic property due to presence of areca 
alkaloids. Four alkaloids have been identified in biochemical studies, arecoline, arecaidine, 
guvacine & guvacoline, of which arecoline is the main agent. These alkaloids have   powerful   
parasympathetic properties   which   produce   euphoria and counteract fatigue. 
Nitrosation of arecoline leads to the formation   of areca nut specific nitrosamine namely   
nitrosoguvacoline, nitrosoguvacine and 3-methyl  nitrosominopropionitrile, which alkylate DNA. 
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Metabolism of these areca nut specific nitrosamine lead   to formation of cyanoethyl, which 
binds with o’methyl   guanine in DNA. Prolonged exposure to this irritant   leads to malignant 
transformation 
66
. 
 αvβ6 INTEGRIN IN ORAL SQUAMOUS CELL CARCINOMA 
  (Maria L. Nystrom et al 2006) Cyclooxygenases (COX) catalyze the key step in 
prostanoid and thromboxane biosynthesis and are targets of non-steroidal anti-inflammatory 
drugs (NSAID). COX-1, expressed constitutively in most mammalian cells, generates 
prostaglandins necessary for normal physiologic function, whereas COX-2, normally 
undetectable, is induced rapidly by stimuli, including cytokines, oncogenes, and tumor 
promoters. Elevated COX-2 expression occurs in many carcinomas, including oral squamous 
carcinoma (OSCC), where it contributes to tumor progression
9
. NSAIDs have marked antitumor 
activity via COX-2 inhibition. COX-2 inhibition might modulate αvβ6 function by reducing cell 
surface expression, decreasing ligand binding affinity, and/or interfering with αvβ6 integrin 
signaling. Both αvβ6 and COX-2 are expressed in OSCC, both which promote invasion, and that 
NSAIDs may inhibit integrin function. NSAIDs could inhibit αvβ6-mediated invasive activity9. 
OSCC cells requires COX-2- dependent activation of Rac-1, via upregulation of PGE2; 
abrogating COX-2, thus, blocks αvβ6-dependent invasion. They are collected from biopsy 
twenty OSCC, 39 epithelial dysplasias (18 transforming to OSCC and 21 non-transforming; 
clinical follow-up range, 5-31 years), and 14 benign polyps showing fibroepithelial hyperplasia 
were chosen at random
9
.
 
αvβ6 INTEGRIN EXPRESSION IN SQUAMOUS CELL CARCINOMA 
(Thomas et al, 2001). αvβ6 promoted oral SCC invasion by increasing migration, pro-
MMP9 production and invasion. αvβ6 dependent processes of oral SCC cells are likely to be 
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modulated in vivo by ligation to a high-affinity, αvβ6 specific ligand for oral SCC cells, the 
TGFb-associated pro-peptide, LAP
56
. 
INTEGRIN αVβ6 IN COLON CANCER CELLS THROUGH MMPs 
 
 (Ylipalosaari et al 2005) Inhibition of integrin αvβ6 expression in colon cancer cells 
suppresses MMP-9 secretion. This integrin-mediated event is dependent upon direct binding 
between the β6 integrin subunit and extracellular signal-regulated kinase 228. They are collected 
from the human colon cancer cell lines
28
. 
  (Guang Yun Yang et al 2008) αvβ6 may mediate the potential for colon cancer cells to 
colonize in and metastasize to the liver. The mechanisms that αvβ6 may be involved in include 
the promotion of MMP-9 secretion, the enhancement of migration on fibronectin, and the 
survival of cancer cells in the liver. They are collected from the human colon cancer cell lines
39
. 
αvβ6 INTEGRIN A MARKER FOR OVARIEN CANCER 
(Nuzhat Ahmed et al 2002) αvβ6 is present in malignant epithelia but not in normal 
epithelia. Normal ovarian surface epithelium was negative for αvβ6 integrin expression.21 The 
αvβ6 expression is associated with ovarian cancer and that the expression of the integrin 
increases with advancing grade in all epithelial ovarian cancer
21
.
 
They are collected from biopsy 
from normal ovaries (N=8) or in benign ovarian serous cyst adenomas (N=8)
21
. 
αvβ6 INTEGRIN EXPRESSION IN COLORECTAL CANCER 
 (Richard C. Bates et al 2005) In colon carcinoma model of Epithelial-Mesenchymal Transition 
(EMT), it was increased expression of the integrin αvβ6 is elicited as a consequence of the 
transition. Importantly, the consequences of the elevated αvβ6 expression are directly linked to 
both tumor cell function and to the mechanism of the Epithelial-Mesenchymal Transition
34
.  
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       (Seong Beom Ahn et al 2014) Integrin αvβ6 is more frequently expressed at the invasive 
front of rectal cancer. While it plays an important role in tumour progression
47. Integrin αvβ6 
directly interacts with the extracellular signal-regulated kinase (ERK2) activating the 
ERK/MAPK pathway that is often highly overexpressed in colorectal cancer (CRC) metastasis. 
They are collected in 362 Stage B or C rectal cancer tissue samples at the tumour central region, 
invasive tumour front and adjacent non-neoplastic mucosa using immunohistochemistry
47
. 
αvβ6 INTEGRIN EXPRESSION IN BREAST CANCER 
        (D Katoh et al 2013) In a colon cancer in vitro model, tumor necrosis factor (TNF)-α and 
transforming growth factor (TGF)-β1 were found to cause upregulation of the β6 subunit and 
consequent increase of αvβ6 heterodimers contributing to Epithelial-Mesenchymal Transition 
(EMT).
 
They are collected from in a colon cancer in vitro model
40
. 
αvβ6 INTEGRIN EXPRESSION IN GASTRIC CANCER 
 
        (Pei-Long Lian et al 2016) The expression of αvβ6 and MMP-9 are closely correlated, and 
the combinational pattern of αvβ6 and MMP-9 can serve as a more effective prognostic index for 
gastric cancer. They are collected from 126 specimens from patients with primary gastric 
carcinoma
61
. 
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RESULTS 
Sample characteristics: 
            The study population includes 40 cases taken from the archival blocks. They were 
categorized into four groups. Group I (n=10) comprised of normal mucosa samples. Group II 
(n=10) comprised of mild epithelial dysplasia samples. Group III (n=10) comprised of both 
moderate and severe epithelial dysplasia samples. Group IV (n=10) comprised of oral 
submucous fibrosis samples. All the samples were analyzed for the immunoreactivity of αvβ6 
integrin stain. 
Distribution of age in the study groups: (Table 1 & Graph 1): 
     The age of the patients in all the study groups was divided into 3 groups: 10-30 years, 
31-50 years and those above 51 years of age. Group I, consists of 3 (30%) cases in the age group 
10-30 years and 5 (50%) cases in the age group 31-50 years and 2 (20%) cases above 51 years. 
Group II, consisted of 1 (10%) cases in the age group 10 -30 years and 1 (10%) cases in the age 
group 31-50 years and 8 (80%) cases above 51 years. Group III, consisted of 3 (30%) cases in 
the age group 31-50 years and 7 (70%) cases above 51 years. Group IV, 2(20%) cases in the age 
group 10-30 years and 5 (50%) cases in the age group 31-50 years and 3 (30%) cases above 51 
years.  
Distribution of gender in the study groups: (Table 2 & Graph 2): 
              In group I, 6 (60%) were males and there were 4 (40%) female. In group II, 7 (70%) 
were males and there were 3 (30%) females.  In group III,   were 6 (60%) males and 4 (40%) 
females. In group IV, 7 (70%) were males and 3 (30%) were females.  
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Distribution of habits in the study groups (Table 3 & Graph 3): 
           Based on the prevalence of habits in the study groups, they were categorized into five 
groups. They were those without any habits, those with habit of chewing tobacco and areca nut 
alone, smoking alone, chewing arecanut and smoking, chewing tobacco and arecanut and 
consuming alcoholic beverages,. In group I (control group) none of them had any habits. In 
group II, there were 3(30%) with habit of chewing tobacco and arecanut alone, 2(20%) had no 
habits, 4(40%) with habit of smoking beedi alone 1(10%) with habit of pan chewing and beedi 
smoking. In group III, 3(30%) with habit of arecanut chewing alone, 4(40%) with had no habits 
and 2(20%) who did not have history of habit recorded, 1(10%) with habit of ghutka chewing 
and consuming alcoholic beverages. In group IV, 9(90%) with habit of arecanut and   tobacco 
chewing alone and 1(10%) with habit of smoking and tobacco chewing. (p= 0.001) 
Distribution of site in the study groups (Table 4 & Graph 4):  
       In group I, 5 (50) biopsies were from retro-molar region and 5 (50%) biopsies were from 
gingiva. In group II, 5 (50%) biopsies were from buccal mucosa and 2 (20%) biopsies were from 
lateral border of tongue and 1 (10%) biopsies was from lower lip and 1 (10%) biopsies was from 
angle of mouth and 1 (10%) biopsies was from left buccal vestibule. In group III, 5 (50%) 
biopsies were from buccal mucosa and 4 (40%) biopsies were from tongue and 1 (10%) biopsies 
were from gingiva. In group IV, 10(100%) biopsies were from buccal mucosa. (p=0.000) 
Distribution of intensity of αvβ6 integrin in the study groups: (Table 5 & Graph 5): 
       Of the total number of cases subjected to αvβ6 Integrin staining, in group I, showed 
10(100%) negative. In group II, showed 1(10%) weak, 2(20%) strong and 7(70%) negative, in 
group III, 1(10%) weak, 3(30%) moderate and 6 (60%) negative, In group IV, showed 3(30%) 
weak, 2(20%) moderate, 3(30%) strong and 2 (20%) negative.(p=0.031) 
Results 
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Tissue localization in αvβ6 integrin positive stained cells in the study groups (Table 6 & 
Graph 6): 
          Of the total number of cases subjected to αvβ6 Integrin staining, in group I, showed 10 
(100%) negative, in group II, showed 1 (10%) supra basal, 2 (20%) full thickness of epithelium 
and 7 (70%) negative, in group III, showed 4 (40%) full thickness of epithelium and 6 (60%) 
negative, in group IV, showed 1 (10%) focal basal, 1 (10%) linear basal, 3 (30%) supra basal, 3 
(30%) full thickness of epithelium and 2 (20%) negative. (p=0.049) 
Comparison of αvβ6 integrin the score of intensity between normal (group I) mild 
dysplasia (group II) and moderate & severe dysplasia (group III): (Tables 7 & Graph 7): 
       Of the total number of cases subjected to αvβ6 Integrin staining, In group II, showed 3 
(30%) high and 7 (70%) negative, in group III, 4 (40%) high and 6 (60%) negative.(p=0.089) 
Comparison of αvβ6 integrin the score of intensity between the normal (group I) and oral 
submucous fibrosis (group IV) : (Tables 8& Graph 8): 
     Of the total number of cases subjected to αvβ6 Integrin staining, in group I, 10 (100%) 
showed negative. In group IV, showed 4 (40%) low, 4(40%) high and 2 (20%) negative. 
(p=0.001) 
Distribution of intensity, localization of αvβ6 integrin expression in patients with and 
without arecanut chewing (Tables 9& Graph 9): 
  We also analyzed the distribution of intensity, localization of αvβ6 integrin in patients 
with and without arecanut chewing of 40 cases, there were 14 (35%) cases with the habits of 
arecanut and 26 (65%) cases without the habits of arecanut chewing. (p=0.019) 
Results 
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In the group of arecanut chewers (n=14) there were 10 (72%) cases expressed αvβ6 
integrin. The expression of αvβ6 integrin was strong in 3 (21%), moderate in 5 (35%), and weak 
in 2 (14%). The expression of αvβ6 integrin was full epithelium in 5 (35%), supra basal layer in 
4 (28%) and focal basal layer in 1 (7%). 
In the group of non arecanut chewers (n=26) there were 5 (19%) cases expressed αvβ6 
integrin. The expression of αvβ6 integrin was strong in 1 (3%), moderate in 1 (3%), and weak in 
3 (11%). The expression of αvβ6 integrin was full epithelium in 4 (15%), and focal basal layer in 
1 (3%). 
KAPPA VALUE: 
      Three observers analyzed the slides for scoring the intensity of staining. The overall Kappa 
value for the inter observer variation is 0.6. 
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TABLE 1:  DISTRIBUTION OF AGE IN THE STUDY GROUPS (N=40) 
AGE IN YEARS 10-30  31-50  ABOVE 51  
GROUP I      n=10 3 (30%) 5 (50%) 2 (20%) 
GROUP II     n=10 1 (10%) 1 (10%) 8 (80%) 
GROUP III    n=10 0 3 (30%) 7 (70%) 
GROUP IV    n=10 2 (20%) 5 (50%) 3 (30%) 
 
GRAPH 1:  DISTRIBUTION OF AGE IN THE STUDY GROUPS (N=40) 
 
GROUP I – NORMAL MUCOSA 
GROUP II – MILD EPITHELIAL DYSPLASIA 
GROUP III – MODERATE & SEVERE DYSPLASIA 
GROUP IV – ORAL SUBMUCOUS FIBROSIS 
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TABLE 2: DISTRIBUTION OF GENDER IN THE STUDY GROUPS (N=40) 
GENDER MALE FEMALE 
GROUP I       n=10 6 (60%) 4 (40%) 
GROUP II     n=10 7 (70%) 3 (30%) 
GROUP III    n=10 6 (60%) 4 (40%) 
GROUP IV    n=10 7 (70%) 3 (30%) 
 
GRAPH 2: DISTRIBUTION OF GENDER IN THE STUDY GROUPS (N=40) 
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TABLE 3: DISTRIBUTION OF HABITS IN THE STUDY GROUPS (N=40) 
HABIT NO 
HABIT 
ARECANUT 
& 
TOBACCO 
CHEWING 
SMOKING 
ALONE 
PAN 
CHEWING 
& 
SMOKING 
ARECANUT 
CHEWING & 
ALCOHOLIC 
BEVERAGES 
 
p Value 
GROUP I  
(n=10) 
10 0 0 0 0  
p=0.001
* 
GROUP 
II (n=10) 
2 (20%) 3 (20%) 4 (40%) 1 (10%) 0 
GROUP 
III (n=10) 
6 (60%) 3 (30%) 0 0 1 (10%) 
GROUP 
IV   
(n=10) 
0 9 (90%) 0 1 (10%) 0 
                                                                                                                                                                         
*p Value < 0.05 is significant 
GRAPH 3: DISTRIBUTION OF HABITS IN THE STUDY GROUPS (N=40) 
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TABLE 4: DISTRIBUTION OF SITE IN THE STUDY GROUPS (N=40) 
SITE BUCCAL 
MUCOSA 
TONGUE GINGIVA RETRO  
MOLAR 
LIP VESTIB
ULE 
ANGLE 
OF 
MOUTH 
p Value 
GROUP I  
(n=10) 
0 0 5 (50%) 5 (50%) 0 0 0  
p=0.000
* 
GROUP II   
(n=10) 
5 (50%) 2 (20%) 0 0 1 
(10%) 
1 (10%) 1 (10%) 
GROUP 
III   (n=10) 
5 (50%) 4 (40%) 1 (10%) 0 0 0 0 
GROUP 
IV   (n=10) 
10 (100%) 0 0 0 0 0 0 
                                                                                                                                                                                      
*p Value < 0.05 is significant 
GRAPH 4: DISTRIBUTION OF SITE IN THE STUDY GROUPS (N=40) 
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TABLE 5 : αvβ6 INTEGRIN STAINING  INTENSITY BETWEEN THE STUDY GROUPS (N=40) 
 
STAINING PRESENT  ABSENT pVALUE 
GROUP I (n=10) 80% 20%  
p=0.003 GROUP II, (n=10) 30% 70% 
GROUP III (n=10) 40% 60% 
GROUP IV (n=10) 0% 100% 
 
* p value < 0.05 is significant 
GRAPH 5: αvβ6 INTEGRIN STAINING  INTENSITY BETWEEN THE STUDY GROUPS (N=40) 
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TABLE 6: COMPARISON OF αvβ6 INTEGRIN STAINING INTENSITY BETWEEN THE 
STUDY GROUPS (N=40) 
 
αvβ6 INTEGRIN 
INTENSITY 
NEGATIVE WEAK MODERATE STRONG p Value 
GROUP  I    n=10 10 (100%) 0% 0 0  
p=0.031
* 
GROUP  II   n=10 7 (70%) 1(10%) 0% 2 (20%) 
GROUP  III   n=10 6 (60%) 1(10%) 3(30%) 0 
GROUP  IV   n=10 2 (20%) 3(30%) 2(40%) 3(30%) 
 
* p value < 0.05 is significant 
 
GRAPH 6: COMPARISON OF αvβ6 INTEGRIN STAINING INTENSITY BETWEEN THE 
STUDY GROUPS (N=40) 
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TABLE 7: TISSUE LOCALISATION IN αvβ6 INTEGRIN POSITIVE STAINED CELLS IN THE 
STUDY GROUPS (N=40) 
  
TISSUE 
LOCALIZATION NEGATIVE 
FOCAL 
BASAL 
LINEAR 
BASAL 
SUPRA 
BASAL 
FULL 
EPITHELIUM 
P Value 
GROUP I       
n=10 10(100%) 0 0 0 0 
 
 p=0.049* 
GROUP II      
n=10 7(70%) 0 0 1(10%) 2(20%) 
GROUP III     
n=10 6(60%) 0 0 0 4(40%) 
GROUP IV    
n=10 2(20%) 1(10%) 1(10%) 3(30%) 3(30%) 
* p value < 0.05 is significant 
GRAPH 7: TISSUE LOCALISATION IN αvβ6 INTEGRIN POSITIVE STAINED CELLS IN THE 
STUDY GROUPS (N=40) 
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TABLE 8: COMPARISON OF αvβ6 INTEGRIN OF THE SCORE OF INTENSITY BETWEEN 
NORMAL AND GRADES OF EPITHELIAL DYSPLASIA (GROUP I , GROUP II & III) (N=30) 
 
GROUPS NEGATIVE 
(0) 
LOW   
(1-4) 
HIGH 
(5-7) 
p Value 
GROUP  I  n=10   10 (100%)        0 0 p=0.089 
GROUP  II    n=10 7 (70%) 0 3 (30%) 
GROUP  III   n=10 6 (60%) 0 4 (40%) 
 
GRAPH 8: COMPARISON OF αvβ6 INTEGRIN OF THE SCORE OF  INTENSITY BETWEEN 
NORMAL AND GRADES OF EPITHELIAL DYSPLASIA (GROUP I , GROUP II & III) N=30 
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TABLE 9: COMPARISON OF αvβ6 INTEGRIN THE SCORE OF INTENSITY BETWEEN 
NORMAL AND ORAL SUBMUCOUS FIBROSIS (GROUP I & GROUP IV) N=20 
GROUPS NEGATIVE 
(0) 
LOW 
(1-4) 
HIGH 
(5-7) 
p Value 
GROUP I      n=10 10 0 0  
p=0.001
* 
GROUP IV   n=10 2 (20%) 4 (40%) 4 (40%) 
 
* p value < 0.05 is significant 
GRAPH 9: COMPARISON OF αvβ6 INTEGRIN THE SCORE OF INTENSITY BETWEEN 
NORMAL AND ORAL SUBMUCOUS FIBROSIS (GROUP I & GROUP IV) N=20  
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TABLE 10 : DISTRIBUTIONS OF INTENSITY, LOCALIZATION OF αvβ6 INTEGRIN 
EXPRESSION IN PATIENTS WITH AND WITHOUT ARECANUT CHEWING (N=40) 
HABIT 
  Intensity 
   Tissue Localization  
 
 
 
 
 
p VALUE 
 
 
Focal 
basal 
linear 
basal 
Supra 
basal 
Full 
epithelium Negative Weak Moderate Strong 
WITH 
ARECANUT 
(n=14) 35% 
4 
(29%) 
2 
(14%) 
5 
(36%) 
3 
(21%) 
1 
(7%) 0.00% 
4 
(29%) 
5 
(36%) 
 
p=0.019
* 
 
WITHOUT 
ARECANUT 
(n=26) 65%  
21 
(80%) 
3 
(12%) 
1 
(4%) 
1 
(4%) 0 
1 
(4%) 0 
4 
(15%) 
 
* p value < 0.05 is significant 
GRAPH 10: DISTRIBUTIONS OF INTENSITY, LOCALIZATION OF αvβ6 INTEGRIN 
EXPRESSION IN PATIENTS WITH AND WITHOUT ARECANUT CHEWING (N=40) 
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DISCUSSION 
 
The purpose of the present study was to investigate the expression of αvβ6 
integrin by epithelial cells in epithelial dysplasia and oral submucous fibrosis and its 
association with malignant transformation of these lesions. Integrins are a family of 
cell surface receptors that mediate cell–cell and cell–extracellular matrix adhesion in 
various cell types including epithelial keratinocytes. αvβ6 integrin is reported to have 
multiple roles in the malignant transformation, including cell adhesion and migration, 
regulation of cell growth and inflammation, and signalling of matrix degradation
2
.  
Oral epithelial dysplasia is a potentially malignant lesion that has the 
potential to undergo malignant transformation (WHO, 1997). As high as 17% of the 
lesions may progress to malignant lesions of the oral cavity. In epithelial dysplasia, 
αvβ6 integrin activates the TGF-β1 through its interaction with the αvβ6 ligands such 
as fibronectin, tenascin, vitronectin and latency-associated peptide (LAP) of the 
cytokine,which in turn activate the basal keratinocytes in the progression of 
dysplastic lesion to malignancy
2
. 
In oral submucous fibrosis,the pathogenesis involves increased accumulation 
of collagen within the lamina propria of the oral mucosa, eventually leading to 
scarring of underlying muscle. Binding of  αvβ6 integrin to the LAP of both TGF-β1 
and TGF-β3 results in activation of the cytokines, which promotes pathogenic organ 
fibrosis. Increased αvβ6 integrin expression promotes keratinocyte migration and 
induced invasion, suggesting that the αvβ6 integrin may play a role in malignant 
transformation.Approximately 7-13% of OSF cases have been reported to progress to 
Oral Squamous Cell Carcinoma
5
. 
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Archival blocks were taken from the department for the present study. The 
study population includes 40 cases. They were categorized into four groups. Group I 
(n=10) comprised of clinically normal mucosa samples which was obtained from 
retromolar and gingiva region of   the patients who came for removal of teeth and 
crown lenghthening. Group II (n=10) comprised of mild epithelial dysplasia samples. 
Group III(n=10) comprised of moderate and severe epithelial dysplasia as a single 
group. Group IV (n=10) comprised of oral submucous fibrosis samples. 
According to Lee CH et al the average diagnostic age of subjects in their 
study who were suffering from epithelial dysplasia was 47.97 ±11.8 years. In the 
present study the average diagnostic age of epithelial dysplasia was 56±10.5 years. 
the average diagnostic age of subjects suffering from OSF was 39 ±12 years
27
. In the 
present study the average diagnostic age of oral submucous fibrosis was 
44±11.5years. Our study was consistent with the Lee CH et al study and the pattern 
of age distribution between the groups was statistically significant.    
In all the groups (II, III and IV), males were more  affected than females. The 
overall male and female ratio was 2:1. According to Lee CH
27
et al study 94% of 
subjects with epithelial dysplasia were males. In our study the male to female ratio 
was 1:1.Our finding was consistent with that of  Antony George
64
 et al who had a 
similar equal prevalence in both males and females. This could be due to the 
increased habitual use of tobacco and alcohol among women 
64
 . 
According to Lee et al betel quid chewing was found to be the strongest risk 
factor associated with both dysplasia and OSF. Along with cigarette smoking this risk 
is significantly elevated. The attributable risk of dysplasia developing from betel quid 
chewing was 73.2% and 85.4% respectively. Combined with cigarette smoking the 
risk of developing dysplasia increased to 84.4%.
27 
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In the present study 40% of epithelial dysplasia had the habit of smoking alone and 
50% of epithelial dysplasia patients had the habit of tobacco chewing and smoking 
and 30% of epithelial dysplasia patients had the habit of arecanut and tobacco 
chewing. None of the patients in the control group had habits  
Integrins are the principal cell surface receptors the enable both normal and 
transformed cells to attach to and respond to their extracellular environment. They 
mediate cell to cell or cell to extracellular matrix adhesion providing adhesion for 
stationary cells. αvβ6 is a fibronectin binding protein. It has both a cytoplasmic and a 
transmembrane domain
43
. 
In this study, in 30% of cases in group II (mild dysplasia) 40% in group III 
(moderate and severe dysplasia) and 80% of group III (OSF) cases expressed αvβ6 
integrin. In the control group, comprising of normal oral mucosa, αvβ6 was not 
expressed in all the cases. Thus there was a significant difference in expression of 
αvβ6 between normal mucosa and dysplastic mucosa and OSF. This non expression 
in normal epithelium is in concurrence with the study done by Mirza et al 
11
who 
states that αvβ6 is an epithelial specific integrin that is not expressed on healthy oral 
epithelium but is upregulated during tissue remodeling, including wound healing and 
carcinogenesis
11
. 
A percentage of dysplastic epithelial lesions are known to undergo malignant 
transformation. Expression of αvβ6 integrin has a role in the tumorigenesis and in 
epithelial repair. Its induction in tumorigenensis could be attributed to its capacity to 
bind to fibronectin and tenascin in the extracellular matrix.  
Of the 30 % of cases, of mild epithelial dysplasia, 2 cases showed expression 
in the entire epithelium of which one case with the entire epithelium had strong 
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intensity and one case showed staining of weak intensity. The staining index based on 
intensity and localization, was done both these two patients had high scoring and 
these two patients had the habit of smoking for over a period of 20 years 
One case of mild epithelial dysplasia with strong expression of αvβ6 and high 
scoring. This patient had areca nut chewing habit along with smoking for only three 
years. Of the 40% of cases of moderate and severe dysplasia, which expressed αvβ6, 
2 patients had staining of the entire epithelium of moderate intensity and high scoring 
index. These two cases had areca nut chewing habit along with tobacco chewing. 
20% of the cases with moderate dysplasia were on the lateral border of the tongue and 
these two cases presented clinically as an ulcer and did not have habits. These two 
cases showed expression in the entire epithelium. Though one case showed moderate 
intense staining and one showed weak staining, their overall scoring index was high. 
This could be attributed to the fact that these two cases presented as ulcers and the 
inflammatory component and the healing process of the ulcers could have induced the 
high intense staining of αvβ611   
Of the 80% of cases of oral submucous fibrosis which expressed αvβ6, 70 % 
of the cases showed moderate to strong expression. The staining localization varied 
from basal to suprabasal to entire epithelium in these cases. In those cases where the 
expression was seen in the entire epithelium, high scoring index was observed and in 
those where basal and supra basal expression was seen, the scoring index was low. 
The mean duration of the habit of chewing arecanut, in these patients was 10±7 and 
the mean age was 39±12. From the findings of this study, we state that irrespective of 
the age and the duration of the habit, those who had the habit of chewing arecanut 
expressed αvβ6 and in those cases where the expression was seen in the entire 
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epithelium, high scoring index was seen compared to those cases where it was 
expressed only in basal and supra basal, who had low scoring scoring index. 
On comparing the intensity between areca-nut users and non-users, it was 
observed that of the 14 areca nut users, 10 (72%) had expression of αVβ6 integrin 
expression of varying degrees while 21 (81%) of the 26 non-areca nut users exhibited 
no expression of αVβ6 integrin expression. This indicates that use of areca nut has a 
definitive role to play in the αVβ6 integrin expression. This phenomenon has been 
previously suggested by several others including Moutasim KA et al in 2011
5
. They 
demonstrated that oral keratinocytes cell lines exposed to areca nut extracts 
upregulates the integrins and αVβ6 integrin expression as well as its functions. They 
deciphered the involvement and modulation of TGF-β1 by αVβ6 integrin expression 
and subsequent myofibroblast transdifferentiation. These modifications could cause 
matrix accumulation, both by increasing the deposition such as collagen-I, the most 
common collagen to be involved in OSMF, and also by decreasing the degradation of 
matrix proteins such as TIMP-1. The present study is in consistent with these reports. 
Our study results show that areca- nut exposure is one of the crucial factor (p value = 
0.019 ), which could explain the high expression of αVβ6 integrin in those cases who 
had this habit compared to those who did not have the habit and five of these cases, 
three showed weak expression. On comparing the tissue localization, αVβ6 integrin 
expression was observed in full epithelium in 5 cases (50%), 4 (40%) in supra-basal 
layers and focally in 1 (10%) of the areca nut users. In non-areca nut users, 66.66% 
(n=4) involved full epithelium.  This was statistically significant. (Table -9). This 
finding was consistent with the published literature. Our findings could be explained 
as follows, areca nut use causes repeated, chronic microtrauma to the buccal mucosa, 
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possibly via the sharp, coarse fibers
67
. The attempt of the epithelium to repair 
following the injury  should cause an increased expression of αVβ6 integrin or 
alternatively, only certain epithelial cell phenotypes that express αVβ6 integrin may 
be altered and possibly control this epithelium driven inflammation. Other cytokines 
such as TGFβ1 could also be implicated in this mechanism.2  
The increased αVβ6 integrin expression in terms of intensity and localization 
in areca nut chewers, as compared to non-areca nut chewers indicate that αVβ6 
integrin expression and areca nut chewing plays a pivotal role in determining the 
inflammation process via the TGFβ1 and myofibroblast transdifferentiation. This 
could be one of the pathway by which the abnormal fibrosis in OSF is caused. Also, 
the elevated αVβ6 integrin expression in areca nut chewers could be the earliest hall 
mark of deviation from normalcy.  
Considering the other stratifications in the study like age, dysplasia etc: the 
difference oral dysplasia expression was significant for arecanut use emphasizing its 
role in epithelial alteration as one of the initial events which leads to fibrosis 
eventually through TGF beta and SMAD
68  
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SUMMARY AND CONCLUSION 
 A total of 40 biopsies were included in this study, comprising of 10 
cases of normal mucosa, 10 cases of mild dysplasia, 10 cases of 
moderate and severe dysplasia, 10 cases of oral submucous fibrosis. 
 The pattern of αvβ6 integrin staining in all the groups was cytoplasmic. 
 In our study, subjects with mild dysplasia and subjects with moderate 
and severe dysplasia showed 30% and 40% αvβ6 integrin positivity 
respectively and also 80% of oral submucous fibrosis showed αvβ6 
integrin positivity 
 None of the normal subjects expressed αvβ6 integrin. In mild dysplasia 
cases, moderate and severe dysplasia cases and in subjects with oral 
submucous fibrosis, αvβ6 integrin positivity was expressed in 30%, 
40% and 80% of cases respectively. This pattern of staining between 
the groups was statistically significant (p=0.031). 
 The difference in localization between epithelial dysplasia and oral 
submucous fibrosis was statistically significant (p=0.049). In subjects 
with mild dysplasia, all the cases showed high scoring index (p=0.089) 
and in oral submucous fibrosis, 40% of cases showed high intensity, 
40% showed low intensity (p=0.001) compared to normal cases. 
 72% of those who used areca nut had expression of αvβ6 integrin but 
only 19% of the non-areca nut chewers expressed αvβ6 integrin 
(p=0.019). 
Summary and Conclusion 
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 Our findings suggest that areca nut influences αvβ6 integrin 
expression. The increase in αvβ6 integrin expression could influence 
myofibroblast transdifferentiation through TGF β activation. 
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